These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15022187)

  • 1. Parkinson's prevalence estimated by a state registry.
    Strickland D; Bertoni JM
    Mov Disord; 2004 Mar; 19(3):318-23. PubMed ID: 15022187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A national registry to determine the distribution and prevalence of Parkinson's disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson's disease.
    Bhidayasiri R; Wannachai N; Limpabandhu S; Choeytim S; Suchonwanich Y; Tananyakul S; Tharathep C; Panjapiyakul P; Srismith R; Chimabutra K; Phanthumchinda K; Asawavichienjinda T
    Neuroepidemiology; 2011; 37(3-4):222-30. PubMed ID: 22133707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Parkinson's disease and parkinsonism in a Colombian population using the capture-recapture method.
    Sánchez JL; Buriticá O; Pineda D; Uribe CS; Palacio LG
    Int J Neurosci; 2004 Feb; 114(2):175-82. PubMed ID: 14702206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Parkinson's disease in entrants on the Nebraska State Parkinson's Disease Registry.
    Bertoni JM; Sprenkle PM; Strickland D; Noedel N
    Mov Disord; 2006 Oct; 21(10):1623-6. PubMed ID: 16874754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population prevalence and incidence of Parkinson's disease in an Australian community.
    Mehta P; Kifley A; Wang JJ; Rochtchina E; Mitchell P; Sue CM
    Intern Med J; 2007 Dec; 37(12):812-4. PubMed ID: 17561942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and incidence of Parkinson's disease in Europe.
    von Campenhausen S; Bornschein B; Wick R; Bötzel K; Sampaio C; Poewe W; Oertel W; Siebert U; Berger K; Dodel R
    Eur Neuropsychopharmacol; 2005 Aug; 15(4):473-90. PubMed ID: 15963700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of antiparkinsonian drugs in Denmark: results from a nationwide pharmacoepidemiological study.
    Brandt-Christensen M; Kvist K; Nilsson FM; Andersen PK; Kessing LV
    Mov Disord; 2006 Aug; 21(8):1221-5. PubMed ID: 16671076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidemiology of Parkinson's disease in the county of Rogaland, Norway.
    Tandberg E; Larsen JP; Nessler EG; Riise T; Aarli JA
    Mov Disord; 1995 Sep; 10(5):541-9. PubMed ID: 8552103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Parkinson's disease in Northwestern Italy: comparison of tracer methodology and clinical ascertainment of cases.
    Chiò A; Magnani C; Schiffer D
    Mov Disord; 1998 May; 13(3):400-5. PubMed ID: 9613728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estimation of the prevalence of Parkinson's disease in Asturia, Spain. A pharmacoepidemiological study of the consumption of antiparkinson drugs].
    Martínez-Suárez MM; Blázquez-Menes B
    Rev Neurol; 2000 Dec 1-15; 31(11):1001-6. PubMed ID: 11190861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Parkinson's disease in the L'Aquila district, central Italy.
    Totaro R; Marini C; Pistoia F; Sacco S; Russo T; Carolei A
    Acta Neurol Scand; 2005 Jul; 112(1):24-8. PubMed ID: 15932352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in the recording of Parkinson's disease on death certificates.
    Pressley JC; Tang MX; Marder K; Cote LJ; Mayeux R
    Mov Disord; 2005 Mar; 20(3):315-21. PubMed ID: 15580618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century.
    Yamawaki M; Kusumi M; Kowa H; Nakashima K
    Neuroepidemiology; 2009; 32(4):263-9. PubMed ID: 19209006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of chronic analgesic drugs prevalence in Parkinson's disease, other chronic diseases and the general population.
    Brefel-Courbon C; Grolleau S; Thalamas C; Bourrel R; Allaria-Lapierre V; Loï R; Micallef-Roll J; Lapeyre-Mestre M
    Pain; 2009 Jan; 141(1-2):14-8. PubMed ID: 19062167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of coffee consumption and risk of Parkinson's disease.
    Sääksjärvi K; Knekt P; Rissanen H; Laaksonen MA; Reunanen A; Männistö S
    Eur J Clin Nutr; 2008 Jul; 62(7):908-15. PubMed ID: 17522612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community-based survey.
    Winquist A; Steenland K; Shankar A
    Mov Disord; 2010 May; 25(7):932-6. PubMed ID: 20310031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily.
    Morgante L; Nicoletti A; Epifanio A; Contrafatto D; Savica R; Lanzafame S; Musolino R; La Spina P; Bonuccelli U; Marconi R; D'Amelio M; Savettieri G; Zappia M
    Parkinsonism Relat Disord; 2008 Nov; 14(7):572-5. PubMed ID: 18325817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Rett syndrome: a population-based registry.
    Kozinetz CA; Skender ML; MacNaughton N; Almes MJ; Schultz RJ; Percy AK; Glaze DG
    Pediatrics; 1993 Feb; 91(2):445-50. PubMed ID: 8424025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease and thyroid dysfunction.
    Munhoz RP; Teive HA; Troiano AR; Hauck PR; Herdoiza Leiva MH; Graff H; Werneck LC
    Parkinsonism Relat Disord; 2004 Aug; 10(6):381-3. PubMed ID: 15261881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.